New And Special Drugs
Anxu (Rovadicitinib) – Myelofibrosis | HongKong DengYue Medicine
Goxblem (Bemiltenase alfa) – Hemophilia A/B | HongKong DengYue Medicine
Kardorisso (Asandeutertinib) – NSCLC | HongKong DengYue Medicine
Atled (Fanregratinib) – Intrahepatic Cholangiocarcinoma | HongKong DengYue Medicine
Redemplo (Plozasiran) – FCS | HongKong DengYue Medicine
Yizekang (Izalontamab Brengitecan) – NPC/ESCC | HongKong DengYue Medicine
Qiyoukang (Gumokimab) – Plaque Psoriasis | HongKong DengYue Medicine
Lukeda (Rocbrutinib) – MCL | HongKong DengYue Medicine
What Can We Offer You?
Generic drugs
Dedicated to providing high-quality, affordable medicines around the world
Vitamins and Supplements
A balanced diet by addressing different deficiencies with the right dosage
brand name medicines
DengYue Medicine as China Drug Import and Export Wholesaler, fills the gap between quality and quantity by adding some affordability
Fast-moving consumer goods
Stock a full range of products from sanitary napkins to foot care creams for your daily needs
non-prescription drugs
Flagship OTC brand - approved and accepted by global standards
Medical supplies and auxiliary supplies
Explore continually updated supplies, diagnostic equipment and essential tools
News
HongKong DengYue Medicine Wholesaler focus on medical trends and obtain new drug directions.
20 FAQs About Medical Treatment in China for Foreigners
This article covers 20 FAQs about medical treatment in China for foreigners, offering practical guidance on healthcare procedures, medical resources, and travel arrangements for international
Medical Tourism in China: A Complete Guide for International Patients (2026)
This comprehensive guide to medical tourism in China covers major medical cities, leading hospitals, popular treatments, costs, and care processes for international patients. It also
Latest Innovative Drugs in China 2026
This article lists the latest innovative drugs in China 2026, including indications, pharmaceutical companies, and approval dates, updated through October 30, 2026. It is regularly
Bayer’s Asundexian Approved in China: A Novel FXIa Inhibitor for Stroke Prevention
On October 26, 2026, China’s NMPA approved Bayer’s novel coagulation factor XIa (FXIa) inhibitor, asundexian, to reduce stroke risk in adults following a non-cardioembolic ischemic
China Rare Disease Drug Catalog: Drug List, Indications, and Approval Information
This China rare disease drug catalog covers rare disease medicines available in China as of October 28, 2026, and is continuously updated as new drugs
New Drug Batoclimab for Myasthenia Gravis Approved in China, Advancing FcRn-Targeted Therapy
On October 22, 2026, China’s NMPA official website showed the approval of batoclimab injection for adults with AChR antibody-positive generalized myasthenia gravis (gMG), in combination
How to Choose Oral Nutritional Supplements for Cancer Patients: Types, Protein Needs & Usage Guide
Malnutrition is a common concern among people with cancer. It may be associated with reduced appetite, adverse effects of anticancer treatment, and disease-related metabolic changes,
Targeted Drugs for Thyroid Cancer by Cancer Type: Common Agents and Molecular Targets
Key Takeaways Thyroid cancer is a common endocrine malignancy. For some patients with advanced, metastatic or progressive disease, targeted therapy provides important treatment options. Hong
Fast And Safe Delivery
Global Transportation Express
Temperature-controlled Transport
Safe Transportation, GDP Compliant
